Nick Glover
2019
In 2019, Nick Glover earned a total compensation of $1.9M as President and Chief Executive Officer at ProNAi Therapeutics, a 1% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $346,420 |
|---|---|
| Option Awards | $904,459 |
| Salary | $607,754 |
| Other | $59,770 |
| Total | $1,918,403 |
Glover received $904.5K in option awards, accounting for 47% of the total pay in 2019.
Glover also received $346.4K in non-equity incentive plan, $607.8K in salary and $59.8K in other compensation.
Rankings
In 2019, Nick Glover's compensation ranked 6,158th out of 13,971 executives tracked by ExecPay. In other words, Glover earned more than 55.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,158 out of 13,971 | 56th |
Division Manufacturing | 2,311 out of 5,695 | 59th |
Major group Chemicals And Allied Products | 841 out of 2,194 | 62nd |
Industry group Drugs | 709 out of 1,880 | 62nd |
Industry Pharmaceutical Preparations | 524 out of 1,392 | 62nd |
Source: SEC filing on April 24, 2020.
Glover's colleagues
We found two more compensation records of executives who worked with Nick Glover at ProNAi Therapeutics in 2019.